ACTIVE

PHARMAPOINT

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

85,6 k €

+159.6% YoY

Gross margin

210,6 k €

-10.0% YoY

Equity

106,3 k €

+0.1% YoY

Workforce

0,9 ETP

-55.0% YoY

What does PHARMAPOINT do?

PHARMAPOINT is a Public limited company incorporated in 1988. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Maasmechelen. It employs on average 0,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0435.330.555

Incorporation

15/09/1988

Legal form

Public limited company

Registered office

Thomasboslaan(M) 98
3630 Maasmechelen · FlandreSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Average workforce

0,9 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	210,6 k €	-10.0%	234 k €	-17.2%	282,5 k €	-12.8%	323,8 k €	+9.5%	295,8 k €	+22.2%	242 k €	-33.9%	366,2 k €	+46.2%	250,5 k €	+7.5%	233 k €	-4.7%	244,5 k €	+22.1%	200,2 k €	+48.5%	134,8 k €	+12.0%	120,4 k €	-66.2%	356,4 k €	+18.7%	300,2 k €	+12.4%	267,2 k €	+7.9%	247,6 k €
EBITDA	171,8 k €	+42.9%	120,2 k €	-41.6%	206,1 k €	-19.4%	255,5 k €	+31.8%	193,9 k €	+65.0%	117,5 k €	-51.6%	242,9 k €	+78.7%	135,9 k €	+15.6%	117,6 k €	-21.5%	149,9 k €	+80.1%	83,2 k €	+4302%	1,9 k €	+103%	-54,9 k €	-126%	207,5 k €	+58.3%	131,1 k €	+29.5%	101,2 k €	+24.2%	81,5 k €
Operating result	127,9 k €	+65.0%	77,5 k €	-53.0%	165,1 k €	-23.9%	216,9 k €	+40.3%	154,6 k €	+148%	62,3 k €	-66.3%	184,9 k €	+162%	70,5 k €	+40.6%	50,1 k €	-38.1%	81 k €	+519%	13,1 k €	+121%	-62,2 k €	+21.6%	-79,3 k €	-139%	205,4 k €	+96.0%	104,8 k €	+42.3%	73,7 k €	+11.5%	66,1 k €
Net result	85,6 k €	+160%	33 k €	-72.2%	118,4 k €	-33.5%	177,9 k €	+65.7%	107,3 k €	+73.9%	61,7 k €	-64.9%	175,8 k €	+158%	68,2 k €	+89.7%	36 k €	-42.1%	62,2 k €	+6699%	-942,2 €	+98.5%	-62 k €	+5.7%	-65,7 k €	-141%	158,9 k €	+49.9%	106 k €	+46.0%	72,6 k €	-0.6%	73,1 k €
Balance sheet
Equity	106,3 k €	+0.1%	106,2 k €	+0.1%	106,2 k €	+0.3%	105,8 k €	+2.8%	103 k €	+12.1%	91,9 k €	+0.0%	91,8 k €	-76.3%	388,1 k €	+21.3%	319,8 k €	+12.7%	283,9 k €	+28.0%	221,7 k €	-0.4%	222,6 k €	-21.8%	284,6 k €	-60.9%	728,9 k €	+27.9%	570 k €	+22.9%	463,9 k €	-15.8%	551,3 k €
Total assets	1 M €	-4.2%	1,1 M €	-2.4%	1,1 M €	-7.2%	1,2 M €	-1.1%	1,2 M €	-2.9%	1,2 M €	-12.1%	1,4 M €	-10.8%	1,6 M €	+0.4%	1,6 M €	+1.9%	1,5 M €	-3.5%	1,6 M €	+11.9%	1,4 M €	+53.7%	924,2 k €	+11.3%	830,6 k €	+19.8%	693,3 k €	+19.4%	580,5 k €	-13.1%	667,7 k €
Cash	10,9 k €	-26.0%	14,7 k €	+1526%	902 €	-92.3%	11,8 k €		–		121,4 k €	+765%	14 k €	-70.6%	47,7 k €	+2.4%	46,5 k €	+43.1%	32,5 k €	+34.6%	24,2 k €	-28.5%	33,8 k €	-39.9%	56,2 k €	-90.2%	571,9 k €	+713%	70,4 k €	+13.9%	61,8 k €	-72.1%	221,1 k €
Debts	914,2 k €	-4.4%	956,2 k €	-2.8%	983,8 k €	-8.1%	1,1 M €	-1.2%	1,1 M €	-4.7%	1,1 M €	-12.9%	1,3 M €	+10.7%	1,2 M €	-5.0%	1,2 M €	-0.5%	1,2 M €	-7.0%	1,3 M €	+13.0%	1,2 M €	+86.1%	638,2 k €	+538%	100 k €	-16.7%	120 k €	+4.4%	114,9 k €	+0.9%	113,9 k €
Other
Workforce	0,9 ETP	-55.0%	2,0 ETP	+17.6%	1,7 ETP	-39.3%	2,8 ETP	0.0%	2,8 ETP	0.0%	2,8 ETP	+12.0%	2,5 ETP	+38.9%	1,8 ETP	0.0%	1,8 ETP	-10.0%	2,0 ETP	-23.1%	2,6 ETP	-16.1%	3,1 ETP	-3.1%	3,2 ETP	-28.9%	4,5 ETP	-4.3%	4,7 ETP	-17.5%	5,7 ETP	+7.5%	5,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 16 ended

Active mandates

Antoon Medaer

Bestuurder · since 29 mai 2021 · until 29 mai 2027

Active

MEDIPHARMA

Gedelegeerd bestuurder · since 29 mai 2021 · until 29 mai 2027 · 0821.792.314

Represented by Ann Hendrix

Active

Ended mandates

Medipharma BV

Gedelegeerd bestuurder · since 29 mai 2021 · until 29 mai 2027

Represented by Ann Hendrix

Ended

Alois Medaer

Director · since 29 mai 2015 · until 29 mai 2021

Ended

ALOIS MEDAER

Director · since 29 mai 2015 · until 29 mai 2020

Ended

BVBA MEDIPHARMA

Managing director · since 29 mai 2015 · until 29 mai 2020

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	12/06/2026	17/06/2025	26/06/2024	30/05/2023	24/06/2022	18/06/2021
General meeting	22/05/2026	23/05/2025	24/05/2024	26/05/2023	27/05/2022	29/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	22/05/2026	12/06/2026	Dutch	PDF
Abridged model	31/12/2024	23/05/2025	17/06/2025	Dutch	PDF
Abridged model	31/12/2023	24/05/2024	26/06/2024	Dutch	PDF
Abridged model	31/12/2022	26/05/2023	30/05/2023	Dutch	PDF
Abridged model	31/12/2021	27/05/2022	24/06/2022	Dutch	PDF
Abridged model	31/12/2020	29/05/2021	18/06/2021	Dutch	PDF
Abridged model	31/12/2019	22/05/2020	03/07/2020	Dutch	PDF
Abridged model	31/12/2018	24/05/2019	03/07/2019	Dutch	PDF
Abridged model	31/12/2017	25/05/2018	31/07/2018	Dutch	PDF
Abridged model	31/12/2016	26/05/2017	03/08/2017	Dutch	PDF
Abridged model	31/12/2015	27/05/2016	03/06/2016	Dutch	PDF
Abridged model	31/12/2014	29/05/2015	01/07/2015	Dutch	PDF
Abridged model	31/12/2013	30/05/2014	30/06/2014	Dutch	PDF
Abridged model	31/12/2012	21/06/2013	01/07/2013	Dutch	PDF
Abridged model	31/12/2011	15/06/2012	23/06/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	12/07/2011	Dutch	PDF
Abridged model	31/12/2009	28/05/2010	21/06/2010	Dutch	PDF
Abridged model	31/12/2008	29/05/2009	15/06/2009	Dutch	PDF
Abridged model	31/12/2007	30/05/2008	04/06/2008	Dutch	PDF
Abridged model	31/12/2006	30/06/2007	02/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 16 ended

Active mandates

Antoon Medaer

Bestuurder · since 29 mai 2021 · until 29 mai 2027

Active

MEDIPHARMA

Gedelegeerd bestuurder · since 29 mai 2021 · until 29 mai 2027 · 0821.792.314

Represented by Ann Hendrix

Active

Ended mandates

Medipharma BV

Gedelegeerd bestuurder · since 29 mai 2021 · until 29 mai 2027

Represented by Ann Hendrix

Ended

Alois Medaer

Director · since 29 mai 2015 · until 29 mai 2021

Ended

ALOIS MEDAER

Director · since 29 mai 2015 · until 29 mai 2020

Ended

BVBA MEDIPHARMA

Managing director · since 29 mai 2015 · until 29 mai 2020

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates13/07/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/08/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/08/2015
ONTSLAGEN - BENOEMINGEN
PDF
Other27/03/2012
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING
PDF
Mandates11/02/2010
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/02/2009
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/12/2004
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202585,6 k €↑
2024
Annual accounts 202433 k €↓
2023
Annual accounts 2023118,4 k €↓
2022
Annual accounts 2022177,9 k €↑
2021
Annual accounts 2021107,3 k €↑
2017
Annual accounts 201761,7 k €↓
2016
Annual accounts 2016175,8 k €↑
2015
Annual accounts 201568,2 k €↑
2014
Annual accounts 201436 k €↓
2013
Annual accounts 201362,2 k €↑
2012
Annual accounts 2012-942,2 €↑
2011
Annual accounts 2011-62 k €↑
2010
Annual accounts 2010-65,7 k €↓
2009
Annual accounts 2009158,9 k €↑
2008
Annual accounts 2008106 k €↑
2007
Annual accounts 200772,6 k €↓
2006
Annual accounts 200673,1 k €
15/09/1988
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMAPOINT

Overview

What does PHARMAPOINT do?

Trend over 17 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline